As of 31 Dec 2025, 1 institutional investors reported holding 2,500 shares of ISHARES TR - ISHARES BIOTECH - Call.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,500 | $421,000 | +$421,000 | $168.77 | 1 |
| 2025 Q3 | $144.37 | 0 | |||
| 2025 Q2 | $126.51 | 0 | |||
| 2025 Q1 | $127.90 | 0 | |||
| 2024 Q4 | $132.21 | 0 | |||
| 2024 Q3 | $145.60 | 0 | |||
| 2024 Q2 | $137.26 | 0 | |||
| 2024 Q1 | $137.22 | 0 | |||
| 2023 Q4 | $135.85 | 0 | |||
| 2023 Q3 | $118.25 | 0 | |||
| 2023 Q2 | $108.99 | 0 | |||
| 2023 Q1 | $114.61 | 0 | |||
| 2022 Q4 | $123.86 | 0 | |||
| 2022 Q3 | $111.61 | 0 | |||
| 2022 Q2 | $115.78 | 0 | |||
| 2022 Q1 | $130.29 | 0 | |||
| 2021 Q4 | $152.62 | 0 | |||
| 2021 Q3 | $161.67 | 0 | |||
| 2021 Q2 | $163.66 | 0 | |||
| 2021 Q1 | $7602.66 | 0 | |||
| 2020 Q4 | $89.79 | 0 | |||
| 2020 Q3 | $135.50 | 0 | |||
| 2020 Q2 | 0 | $0 | -$204,000 | $136.69 | 0 |
| 2020 Q1 | 1,900 | $204,000 | +$204,000 | $107.75 | 1 |
| 2019 Q4 | 0 | $0 | -$1,860,000 | $120.51 | 0 |
| 2019 Q3 | 18,700 | $1,860,000 | +$1,860,000 | $99.47 | 1 |
| 2019 Q2 | $108.19 | 0 | |||
| 2019 Q1 | 0 | $0 | -$70,000,000 | $58.74 | 0 |
| 2018 Q4 | 200 | $70,000,000 | +$69,340,000 | $96.43 | 1 |
| 2018 Q3 | 5,500 | $660,000 | +$660,000 | $120.97 | 1 |
| 2018 Q2 | $55.37 | 0 | |||
| 2018 Q1 | $106.75 | 0 | |||
| 2017 Q4 | $2.93 | 0 | |||
| 2017 Q3 | $330.54 | 0 | |||
| 2017 Q2 | $310.00 | 0 | |||
| 2017 Q1 | 0 | $0 | -$2,760,000 | $293.23 | 0 |
| 2016 Q4 | 10,400 | $2,760,000 | +$2,760,000 | $265.36 | 1 |
| 2016 Q3 | 0 | $0 | -$36,000 | $289.46 | 0 |
| 2016 Q2 | 1,200 | $36,000 | $30.00 | 1 | |
| 2016 Q1 | $260.80 | 0 | |||
| 2015 Q4 | 0 | $0 | -$32,000 | $338.33 | 0 |
| 2015 Q3 | 70,000 | $32,000 | +$32,000 | $303.33 | 1 |
| 2015 Q2 | $368.97 | 0 | |||
| 2015 Q1 | $331.57 | 0 | |||
| 2014 Q4 | $303.35 | 0 | |||
| 2014 Q3 | $273.63 | 0 | |||
| 2014 Q2 | $255.98 | 0 | |||
| 2014 Q1 | $233.49 | 0 |